odm-208
orion pharma,orion
['odm-208 ', 'crpc', 'cypides', 'medsir']
preliminary results of the phase 2 expansion cypides study show a promising antitumor activity of odm-208 in heavily pre-treated mcrpc patients with androgen receptor lbd mutation. odm-208 highly suppressed production of steroid hormones. amazing talk by dr. #karimfizazi #esmo22 
Bring your idea to life??Creating successful IITs & optimal drug development??Medica Scientia Innovation Research????????https://t.co/cciUf0lqpM